Controlling the replication of HIV-1 with a quadruplet codon in mammalian cells

Yan Chen Author

04/03/2021 Added

37 Plays

Description

Student research day presentation.

Searchable Transcript

Search:

[00:00:00.900]Hi, my name is Yan. I'm a graduate student from the department of chemistry.
[00:00:06.140]My advisor is Dr.Jiantao Guo
[00:00:07.730]My project is controlling the replication of HIV-1
[00:00:12.530]with a quadruplet codon in mammalian cells.
[00:00:16.340]I will introduce my project in five parts, background,
[00:00:19.790]objective, methods, results. And the conclusion
[00:00:24.560]first, I will start with the background.
[00:00:27.660]In natural, we have 61 sense triplet codons. They can decode 20 nature amino acids.
[00:00:32.990]In additional, there're also three stop codons.
[00:00:36.380]People are thinking about if we can assign unnatural amino acid,
[00:00:38.970]to these three stop codons, we can expand the genetic code.
[00:00:44.060]Also with unnatural amino acids,
[00:00:46.460]we can introduce novel function to the proteins.
[00:00:50.600]Next, I want to show you how we incorporate unnatural amino acids to the proteins.
[00:00:54.890]First, I will use triplet stop code on as an example,
[00:00:58.700]to incorporate unnatural amino acids,
[00:01:00.560]we need two important components tRNA and the tRNA synthetase enzyme.
[00:01:05.060]tRNA synthetase
[00:01:07.010]is a enzyme can add unnatural amino acids to its corresponding tRNA.
[00:01:11.870]In the translation process,
[00:01:13.490]tRNA charged with unnatural amino acids can recognize the stop codons
[00:01:18.080]The unnatural amino acids can be added to the growing peptides.
[00:01:22.070]eventually this unnatural amino acids can be incorporated to the proteins.
[00:01:28.490]Using quadruple codon to decode unnatural amino acids.
[00:01:32.150]This process is very similar. Again,
[00:01:35.300]we need tRNA and tRNA synthetase in this case, the tRNA will
[00:01:40.250]have a four nucleotides anti-codon loop and in the translation the tRNA can
[00:01:45.200]recognize the quadruplet codon.
[00:01:47.540]And unnatural amino acid can be incorporated to the protein eventually.
[00:01:51.050]With quadruplet codon,
[00:01:53.750]we can further expand that genetic code because we'll have 256
[00:01:58.610]available quadruplet codons to decode unnatural amino acids.
[00:02:03.050]My project focused on HIV-1.
[00:02:05.450]This is a virus which can damage the immune system. Up to now,
[00:02:10.010]multiple HIV-1 vaccine are in development. However,
[00:02:13.880]based on the safety concern, none of them have been tested in the clinical trials.
[00:02:18.980]One of the concern is how can we control HIV-1 replication?
[00:02:24.140]Our strategy is we can use unnatural amino acid incorporation.
[00:02:28.850]The objective of my project is we want to use unnatural amino acid incorporation
[00:02:32.730]to control the HIV-1 replication,
[00:02:37.910]our program can be a potentially applied to the development of a safer
[00:02:42.860]HIV-1 vaccine. To achieve this goal,
[00:02:47.270]we introduce this quadruplet codon UAGA in the HIV-1 genome.
[00:02:52.460]With the tRNA synthetase enzyme and the tRNA, this quadruplet codon can
[00:02:57.290]decode an unnatural amino acid.
[00:02:59.590]And the first condition, when the unnatural amino acid is in present.
[00:03:03.250]The HIV-1 genome can be fully translated and synthesize fully
[00:03:08.060]functional virus. This virus can be potentially developed
[00:03:12.970]as a safe vaccine to trigger the immune response in human beings.
[00:03:17.920]In the other condition, when unnatural amino acid in absence,
[00:03:21.310]the translation will stop at the position of this quadruplet codon.
[00:03:25.750]So there'll be no virus generated. In this way, we can control the virus replication
[00:03:30.340]with the unnatural amino acids.
[00:03:33.610]Another advantage of this system is quadruplet codon
[00:03:36.580]is more difficult to mutate back to sense codons,
[00:03:40.060]even the virus have a relatively higher mutation rate.
[00:03:44.890]Before we testing our control system, We also want to test
[00:03:48.040]if this engineered tRNA variant have a good decoding efficiency in
[00:03:52.450]mammalian cell. This is a tRNA variant
[00:03:55.600]our group previously developed from the bacteria platform.
[00:04:00.700]To test the tRNA decoding efficiency. We constructed this two-plasmid system.
[00:04:05.800]We use Green Fluorescence Protein as a reporter gene.
[00:04:09.340]We introduced a quadruplet codon in the middle of the GFP.
[00:04:14.110]If the tRNA have a good efficiency to incorporate unnatural amino acid in this position,
[00:04:18.760]we will observe a strong fluorescence intensity.
[00:04:23.620]And then we co-transfect these two plasmids to the mammalian cell Hek 293T.
[00:04:27.490]We first took microscope images.
[00:04:32.350]From here, We can clearly observe green fluorescence signals.
[00:04:35.740]We also run the flow cytometry analysis. Combine these two results,
[00:04:40.420]we confirmed that the tRNA variant-1 has the best decoding efficiency.
[00:04:45.220]because we can detect strong fluorescence intensity with this tRNA variant
[00:04:53.080]To test if the control system works well,
[00:04:55.330]we construct this plasmid. In this plasmid, it contains HIV-1 genome.
[00:05:01.150]And also we have introduced a quadruplet codon in the HIV-1 genome.
[00:05:06.610]And then, we transfer this plasmid to HEK 293T cells,
[00:05:10.960]When unnatural amino acid is in present.
[00:05:13.810]The HEK 293T cells can produce HIV virus.
[00:05:18.190]And then, we'll use the virus to infect a reporter cell.
[00:05:21.970]This reporter cell can produce luminance when they are infected by HIV virus.
[00:05:26.830]And in the other case, when unnatural amino acid is in absent.
[00:05:30.770]The HEK 293T cells
[00:05:32.730]can not generate any functional HIV-1 virus.
[00:05:37.240]In theory,
[00:05:38.080]we cannot detect any luminance from the reporter cells, because the reporter cells
[00:05:42.910]are not infected by the HIV virus.
[00:05:46.600]We tested two different position to introduce the quadruplet codons.
[00:05:51.130]This is the results of the infectivity assay.
[00:05:55.480]From the infectivity assay result,
[00:05:57.560]we confirmed that HIV replication is tightly controlled by the unnatural amino acids.
[00:06:02.240]because we can only observed strong luminance signals
[00:06:07.190]when the unnatural amino acid is in present in both positions.
[00:06:11.870]In conclusion, firstly,
[00:06:14.180]we evaluate an engineered tRNA in mammalian cells.
[00:06:19.370]And we have found a variant which have a very good
[00:06:22.460]decoding efficiency in mammalian cells.
[00:06:26.180]Secondly, we confirmed that we can control the virus
[00:06:28.700]replication tightly in mammalian cells with the quadruple codons.
[00:06:31.940]Our results can potentially apply to a safer
[00:06:36.470]HIV-1 vaccine development and help us to fight with this disease.
[00:06:42.590]Lastly, I want to thank my advisor,
[00:06:46.040]Dr.Jiantao Guo and my committee members.
[00:06:49.520]Also, I want to thank my current and former group members.
[00:06:53.960]Lastly, I want to thank my collaborators.
[00:06:56.360]They helped me to accomplish these project together. Thank you.

The screen size you are trying to search captions on is too small!

You can always jump over to MediaHub and check it out there.

Comments

0 Comments

Controlling the replication of HIV-1 with a quadruplet codon in mammalian cells

Description

Searchable Transcript

Comments icon comment

Related Channels

Comments